No abstract available
MeSH terms
-
Biomarkers
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Clinical Trials as Topic
-
DNA Mutational Analysis
-
Drug Resistance, Neoplasm
-
Endpoint Determination
-
ErbB Receptors / antagonists & inhibitors
-
ErbB Receptors / genetics
-
Erlotinib Hydrochloride
-
Forecasting
-
Gene Amplification
-
Humans
-
Lung Neoplasms / drug therapy*
-
Prognosis
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Quinazolines / adverse effects
-
Quinazolines / therapeutic use*
Substances
-
Biomarkers
-
Protein Kinase Inhibitors
-
Quinazolines
-
Erlotinib Hydrochloride
-
ErbB Receptors